Hamps Bio Limited
- Minimum Investment₹1,02,000
- Price Range₹51 - ₹51
- Issue Size₹6.22 Cr
- Lot Size2000 shares
This stock belongs to the SME (Small & Medium Enterprises) segment which usually has low liquidity and hence, is also riskier. It will be traded in a lot size of 2000 shares after listing.
Proceeds of this IPO to be used for
Purchase of plant & machinery for the FMCG division
Enhancing the visibility and awareness of the brand
General corporate purposes
Strengths & Weaknesses of Hamps Bio Limited
Diversified range of products
The company has expanded its product portfolio to include antibiotics, analgesics, antioxidants, calcium, cardiac-diabetic products, injectables, IVs, and freeze-dried fruits, vegetables, and herbs, with 39 registered trademarks
Diversified & global customer base
The company serves 210 customers, including 56 in Pharma and 154 in FDFP products, operating on purchase orders rather than long-term supply contracts
Geographical Presence
The company operates in 22 states and exports to 6 countries, based on sales data as of October 31, 2024, and previous financial years
Depend on third-party manufacturers
The company relies on third-party manufacturers to procure pharmaceutical products, as it does not own a manufacturing facility
Licenses and approvals
The company operates in a highly regulated industry, requiring multiple statutory and regulatory permits, licenses, and approvals. Failure to obtain or renew these approvals could adversely affect its business operations
Presence of counterfeit drugs
The presence of counterfeit drugs mimicking the company's products and the emergence of alternative pharmaceuticals driven by technological advances or changing consumer needs could harm its goodwill, operations, financial results, and business prospects
Financials
Earnings Per Share
No Data
Balance Sheet
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Total Current Assets | -- | |
Total Non-Current Assets | -- | |
Fixed assets | -- | |
Total assets | -- | |
Total Current Liabilities | -- | |
Total Non-Current Liabilities | -- | |
Total Capital Plus Liabilities | -- | |
Total Shareholder Funds | -- | |
Total Debt to Equity | -- |
Cash Flow
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Cash from Operating Activity | -- | |
Cash from Financing Activities | -- | |
Cash from Investing Activities | -- | |
Net Cash Flow | -- |
About Hamps Bio Limited
- PromoterHerrik Shah
- PromoterHerrik Shah (HUF)
- PromoterShrenik Shah
- PromoterShrenik Shah (HUF)
- PromoterPallavi Shah
- PromoterMitali Shah